Asahito Hama1, Takashi Taga2, Daisuke Tomizawa3, Hideki Muramatsu1, Dai-Ichiro Hasegawa4, Souichi Adachi5, Koji Kato6, Maiko Noguchi7, Masami Inoue8, Keiko Okada9, Katsuyoshi Koh10, Yoshiko Atsuta11, Hiroyuki Ishida12 (1.Nagoya University Graduate School of Medicine, Nagoya, Japan, 2.Department of Pediatrics, Shiga Medical University, Otsu, Japan, 3.Division of Leukemia, National Center for Child Health, Tokyo, Japan, 4.Department of Hematology/Oncology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan, 5.Department of Human Health Science, Kyoto University, Kyoto, Japan, 6.Department of Pediatrics, Red Cross Nagoya First Hospital, Nagoya, Japan, 7.Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan, 8.Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Izumi, Japan, 9.Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan, 10.Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan, 11.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 12.Department of Pediatrics, Kyoto City Hospital, Kyoto, Japan)
Session information
Oral Session
Oral Session 1-5A AML: AlloHSCT
Fri. Oct 12, 2018 9:00 AM - 10:00 AM No.5 (Osaka International Convention Center, 12F Grand Toque)
Chair: Kazuteru Ohashi (Tokyo Metropolitan Komagome Hospital, Japan)
Masamitsu Yanada1, Masayoshi Masuko2, Jinichi Mori3, Jun Aoki4, Shohei Mizuno5, Takahiro Fukuda6, Kazuhiko Kakihana7, Yukiyasu Ozawa8, Shuichi Ota9, Heiwa Kanamori10, Takehiko Mori11, Hirohisa Nakamae12, Tetsuya Eto13, Souichi Shiratori14, Tetsuo Maeda15, Koji Iwato16, Tatsuo Ichinohe17, Yoshinobu Kanda18, Junji Tanaka19, Yoshiko Atsuta20,21, Shingo Yano22 (1.Aichi Cancer Center, Nagoya, 2.Niigata University Medical and Dental Hospital, Niigata,, 3.Jyoban Hospital Tokiwa Foundation, Fukushima, 4.Yokohama City University Medical Center, Yokohama, 5.Aichi Medical University, Nagakute, 6.National Cancer Center Hospital, Tokyo, 7.Tokyo Metropolitan Komagome Hospital, Tokyo, 8.Japanese Red Cross Nagoya First Hospital, Nagoya, 9.Sapporo Hokuyu Hospital, Sapporo, 10.Kanagawa Cancer Center, Yokohama,, 11.Keio University School of Medicine, Tokyo, 12.Osaka City University, Osaka, 13.Hamanomachi Hospital, Fukuoka, 14.Hokkaido University Faculty of Medicine, Sapporo, 15.Osaka University Graduate School of Medicine, Osaka, 16.Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima, 17.Hiroshima University Hospital, Hiroshima, 18.Jichi Medical University, Shimotsuke, 19.Tokyo Women's Medical University, Tokyo, 20.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, 21.Nagoya University Graduate School of Medicine, Nagoya, 22.Jikei University School of Medicine, Tokyo)
Takeshi Saito, Hiroki Yokoyama, Hiroto Ishii, Susumu Tanoue, Atsushi Katsube, Yutaro Kamiyama, Ryoko Fukushima, Shoko Ishii, Daiki Hattori, Kurumi Ishimi, Jiro Minami, Takaki Shimada, Shingo Yano (Oncol and Hematol, Jikei Univ, Tokyo, Japan)
Hidetoshi Irifune1,2, Teppei Sakoda1,2, Yoshikane Kikushige2, Goichi Yoshimoto2, Toshihiro Miyamoto2,3, Koichi Akashi1,2,3 (1.Center for Cellular & Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan, 2.Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 3.Department of Hematology, Oncology & Cardiovascular, Kyushu University Hospital, Fukuoka, Japan)
Satoshi Yamasaki1, Jun Aoki2, Jinichi Mori3, Kaito Harada4, Masashi Sawa5, Naoyuki Uchida6, Kazuteru Ohashi7, Takahiro Fukuda8, Shiro Koh9, Heiwa Kanamori10, Hiroyasu Ogawa11, Hirokazu Okumura12, Tatsuo Ichinohe13, Yoshinobu Kanda14, Junji Tanaka15, Yoshiko Atsuta16, Masamitsu Yanada17, Shingo Yano18 (1.Dpt.Hematol.,Kyushu Medical Center,Fukuoka,Japan, 2.Dpt.Hematol.,Yokohama City University Medical Center,Yokohama,Japan, 3.Dpt.Hematol.,Jyoban hospital,Iwaki,Japan, 4.Dpt.Hemato-Oncology,Tokai University School of Medicine,Isehara,Japan, 5.Dpt.Hemato-Oncology,Anjo Kosei Hospital,Anjo,Japan, 6.Dpt.Hematol.,Toranomon Hospital,Tokyo,Japan, 7.Hematology Division,Komagome Hospital,Tokyo,Japan, 8.Div.HSCT,National Cancer Center Hospital,Tokyo,Japan, 9.Dpt.Hematol.,Fuchu Hospital, Fuchu,Japan, 10.Dpt.Hematol.,Kanagawa Cancer Center,Yokohama,Japan, 11.Dpt.Hematol., Hyogo College of Medicine,Kobe,Japan, 12.Dpt of Internal Medicine,Toyama Prefectural Central Hospital,Toyoma,Japan, 13.Dpt.Hemato-Oncology,Hiroshima University,Hiroshima,Japan, 14.Div.Hematol.,Jichi Medical University Saitama Medical Center,Saitama,Japan, 15.Dpt.Hematol.,Tokyo Women's Medical University,Tokyo,Japan, 16.Dpt. Healthcare Administration,Nagoya Univ. Graduate School of Medicine,Nagoya,Japan, 17.Dpt.Hemato-Oncology,Fujita Health University School of Medicine,Toyoake,Japan, 18.Dpt.Hemato-Oncology,Jikei University School of Medicine,Tokyo,Japan)
Hirotaka Sakai, Yusuke Saiki, Akiko Uchida, Yu Uemura, Kazuyuki Sato, Satoshi Yokoi, Yuji Nishio, Manabu Matsunawa, Yasushi Isobe, Masayuki Kato, Naoto Tomita, Ikuo Miura (St. Marianna University School of Medicine, Kanagawa, Japan)